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Abstract: This report was designed to compare spaceflight-induced cellular and physiological adap-
tations of Candida albicans cultured in microgravity on the International Space Station across several
payloads. C. albicans is a common opportunistic fungal pathogen responsible for a variety of su-
perficial infections as well as systemic and more severe infections in humans. Cumulatively, the
propensity of this organism to be widespread through the population, the ability to produce disease
in immunocompromised individuals, and the tendency to respond to environmental stress with char-
acteristics associated with increased virulence, require a better understanding of the yeast response to
microgravity for spaceflight crew safety. As such, the responses of this yeast cultivated during several
missions using two in-flight culture bioreactors were analyzed and compared herein. In general,
C. albicans had a slightly shorter generation time and higher growth propensity in microgravity as
compared to terrestrial controls. Rates of cell filamentation differed between bioreactors, but were
low and not significantly different between flight and terrestrial controls. Viable cells were retrieved
and cultured, resulting in a colony morphology that was similar between cells cultivated in flight and
in terrestrial control conditions, and in contrast to that previously observed in a ground-based micro-
gravity analog system. Of importance, yeast demonstrated an increased resistance when challenged
during spaceflight with the antifungal agent, amphotericin B. Similar levels of resistance were not
observed when challenged with the functionally disparate antifungal drug caspofungin. In aggre-
gate, yeast cells cultivated in microgravity demonstrated a subset of characteristics associated with
virulence. In addition, and beyond the value of the specific responses of C. albicans to microgravity,
this report includes an analysis of biological reproducibility across flight opportunities, compares
two spaceflight hardware systems, and includes a summary of general flight and payload timelines.
Keywords: microgravity; spaceflight; yeast; amphotericin B; caspofungin; antifungal; ISS; Space X;
FPA; GAP; FEP bag
1. Introduction
Candida albicans (C. albicans) is a commensal fungus found throughout the human
body in locations such as the mouth, gastrointestinal tract, vagina, and skin [1,2]. Most
infections are superficial, such as fungal nails, yet as an opportunistic pathogen, this yeast
is capable of causing severe, life-threatening illness in immunocompromised hosts; there-
fore, it is a potential concern for crew during long term spaceflight [3–6]. In addition, the
dichotomy between the commensal and pathogenic behaviors of C. albicans is complex
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and the molecular events responsible for converting a normally benign commensal into a
highly pathogenic organism, which in systemic infections can produce 30–45% mortality,
have not been fully elucidated [7–11]. Moreover, the therapeutic repertoire to treat systemic
Candida infections is limited [12]. There are four classes of antifungal agents used clinically,
including polyenes (e.g., Amphotericin B), echinocandins (e.g., caspofungin), azoles (e.g.,
fluconazole) and nucleoside analogs (e.g., flucytosine) [13]. Amphotericin B (AmB) was
utilized as an early therapeutic for Candida infections and its derivatives remain among the
most effective treatments for systemic disease [14–16]. For these reasons, AmB was chosen
for analyses in the microgravity-associated susceptibility studies described herein. It has
been proposed that AmB functions at the level of the cell membrane, where it interacts
with the yeast-specific sterol, ergosterol, forming pores and compromising membrane in-
tegrity [13,15]. In contrast, caspofungin (CAS) was used to evaluate the yeast response to an
antifungal agent harboring a mechanism of action distinct from that of AmB. Caspofungin
compromises cell wall formation by inhibiting (1–3)-β-D-glucan synthase [11].
C. albicans is a dimorphic eukaryotic organism consisting of spherical yeast form cells
and elongated filamentous cells and has been shown to respond to environmental stresses
such as temperature, pH, and altered gas environments with physiological characteristics
often associated with virulence [17–20]. Indeed the extreme environment of microgravity
presents a unique challenge for organisms that have evolved under normal gravity. Micro-
gravity may provide novel environmental stress cues leading to physiological adaptations
or may allow insights into molecular pathways otherwise masked by a gravity-based
environment, such as that described for the Pseudomonas Hfq pathway [21,22]. Among the
potential adaptations of interest are those properties of C. albicans, on both the single and
multicellular level, that enable it to infect an immunocompromised host. A well-studied
phenotypic transition in C. albicans is filamentation, or hyphal/pseudohyphal formation,
which can be induced by a variety of environmental conditions including temperature,
pH, serum, elevated CO2 and hypoxia [23–25]. The combination of filamentous and yeast
form cells can also form biofilms, or multicellular communities, contributing to increased
virulence and enhanced resistance to environmental insults. As such, C. albicans, particu-
larly in community form, has been documented to have increased resistance to antifungal
agents [4,26,27]. In short, this yeast is capable of altering its phenotype in a number of ways
to become better suited for infection and the environmental cues responsible for initiating
these transitions are numerous. Hallmarks of an infectious form of C. albicans include
robust growth, filamentation, biofilm production and resistance to antifungal agents. The
studies included herein will focus on these yeast characteristics to determine whether
microgravity represents an environmental cue with the potential to alter virulence.
Due to limited access and the expense of spaceflight opportunities, ground-based sim-
ulators, such as rotating wall vessels or random positioning machines, have been used to
generate a ‘modeled microgravity’ environment in order to predict the response of cells to
spaceflight microgravity [28–33]. High Aspect Ratio Vessels (HARV) are rotating-wall ves-
sels that, by revolving about an axis perpendicular to the gravitational vector, create a state
of functional weightlessness and minimal fluid shear within the chamber. Low-fluid shear
may indeed be an important environmental signal for organisms cultivated in microgravity.
Reduced convection and diminished bulk flow may resulted in an altered cell-associated
microenvironment through depletion of nutritional components and accumulation of waste
products [34]. Interestingly, when cultivated in analog bioreactors or in the true micrograv-
ity environment, many, but not all, organisms display morphological and genetic changes
consistent with increased virulence and invasive behavior [22,31,35–38]. Previous studies
of C. albicans cultured in HARV bioreactors demonstrated adaptations that included cells
with increased filamentation, increased resistance to the antifungal agent AmB, altered
colony morphology, and altered biofilm complexity [29,31]. The studies described herein
focus on whether exposure of C. albicans to true microgravity induces similar adaptation
responses to those observed in ground-based analog studies, especially as they relate to
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the potential for increased virulence. Embedded in these studies are comparisons between
spaceflight experiments and between two separate flight hardware systems.
2. Materials and Methods
2.1. Yeast Strain and Growth Conditions
C. albicans (SC5314, American Type Culture Collection) was maintained as a frozen
stock at −80 ◦C. Routinely, and specifically the week before flight preparations, streak
plates were initiated from frozen stock. As needed for experiment preparation, isolated
colonies were used to initiate overnight planktonic cultures. For ground-based studies and
flight sample preparation, all cells were cultured in YPD (1% yeast extract, 2% peptone,
2% glucose, Becton Dickinson, Franklin Lakes, NJ, USA) at 30 ◦C with shaking at 225 rpm
for up to 18 h for planktonic cultures and inverted for 3 days for plated colonies, unless
otherwise noted in specific methods.
2.2. Missions: Common Procedures
Pre-flight sample preparation was done at Kennedy Space Center in the Space Sta-
tion Processing Facility (SSPF). Freshly prepared yeast streak plates, and any specialized
reagents or equipment, were shipped overnight to the SSPF laboratory. These reagents
were shipped in replicate on consecutive days to minimize any complications of potential
transport delays. The research team arrived approximately 10 days prior to launch, navi-
gated the necessary badging and training requirements within the site-specific scheduling
and availability, received the shipments of biologics, and began experimental preparations
forthwith. Flight and terrestrial control samples, with a predetermined and condition-
specific sample excess (spares), were prepared in bulk whenever possible. Following an
incubation period, the bulk-prepared samples were inspection for contamination and other
anomalies (bubbles, volume discrepancies, etc.), and removed from the population as nec-
essary. From the remaining samples, flight and terrestrial control specimens were chosen
and extra samples were deconstructed, cleaned, and sterilized should they be needed for
reloading in the event of an extended launch delay. It should be noted that selection of
flight and terrestrial control samples was essentially random other than verifying that flight
hardware was imperfection free (no glass chips/cracks, no angled septa, etc.). Following
launch, the terrestrial control samples were shipped overnight to the Montana-based labo-
ratory at the appropriate temperature using phase change packaging as needed. Flight and
terrestrial control experiments were conducted near synchronously; the offset time being
determined before flight and allowing for communication of each procedure from the flight
crew, to the Implementation Partner (BioServe Space Technologies, Boulder, CO, USA),
and then to the research team. Mission-specific timing is included in Table 1. In addition,
Figure 1A,B synopsize the hardware utilized in each mission as well as the general contents
and construction of the experimental samples. Specific experimental design details will
be provided in the payload-specific sections below and are summarized in Figure 1C. To
clarify the payload nomenclature, flight experiments are provided with an organizational
name, in our case by NASA Space Biology as part of their funded microbial series of studies
(Micro-x), and the payloads become broadly referred to by these names. The payloads
(experiments) are manifested on a spaceflight mission once preflight requirements have
been met and flight resources (space on a launch vehicle, crew time, International Space
Station (ISS)- based resources) become available. Our first set of experiments is referred to
as Micro-6, which was flown on Space X Cargo Resupply Service (CRS)-1, with a reflight
referred to as Micro-8, flown on Space X CRS-4. The next set of experiments (Micro-14) was
split between two missions so is further defined, for the benefit of clarity herein, by the
hardware used, specifically the Fluid Processing Apparatus (FPA) and Fluorinated Ethylene
Propylene (FEP) bags. Micro-14/FPA was flown on Space X CRS-16 and Micro-14/FEP was
flown on Space X CRS-17. The details of each payload/experiment are described in detail
below. In each case, the C. albicans inoculum was prepared and stored in sterile water to
maintain stasis. Experiments were initiated, or activated, by the addition of the inoculum
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to medium to stimulate growth. Following the defined growth period, experiments were
terminated by the addition of fixative or by placing the samples at a restricted temperature
(−95 ◦C or 4 ◦C, depending on the experiment). Upon completion of the mission and once
the samples were received in the home laboratory, yeast were isolated from the hardware,
which in many cases required deconstruction of the hardware components (de-integration),
and processed as indicated for each of the specific outcome measures.





Figure 1. Schematic representation of the hardware and experimental designs used in the mission payloads. (A) FPA 
bioreactors were used for the Micro-6/8 and Micro-14/FPA payloads and were loaded with two or three chambers, loaded 
in sequence, and separated by rubber septa. Medium was loaded in chamber A (2.7 mL in three chamber design, 5 mL in 
two chamber design) and cell inoculum was loaded in chamber B (0.5 mL). In the three chamber design, chamber C was 
loaded with 2.2 mL of fixative or fresh medium. Chambers were sequentially mixed on a predetermined schedule by 
depressing a plunger, and consequently the column of reagents and septa, to allow mixing of reagents through the bypass 
in the glass barrel. All eight FPAs within a GAP were processed as a unit. At the conclusion of the experimental operations, 
the FPAs were stored within the GAP at the prescribed temperature. (B) FEP bags were used for the Micro-14/FEP payload, 
allowing for dilution (D1 and D2 bags) and serial subculture procedures. To activate growth, yeast (1 mL, 4 × 104 cells/mL) 
was injected into the first Large FEP bag (Bag A containing 11 mL YPD) and cultured for 24 h +/- 1 h at 30 °C. At the end 
of this growth stage, an aliquot was removed and diluted 20-fold (Bag AD1). From this dilution, the next Large FEP bag 
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Figure 1. Schematic representation of the hardware and experimental designs used in the mission
payloads. (A) FPA bioreactors were used for the Micro-6/8 and Micro-14/FPA payloads and were
loaded with two or three chambers, loaded in sequence, and separated by rubber septa. Medium was
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loaded in chamber A (2.7 mL in three chamber design, 5 mL in two chamber design) and cell inoculum
was loaded in chamber B (0.5 mL). In the three chamber design, chamber C was loaded with 2.2 mL
of fixative or fresh medium. Chambers were sequentially mixed on a predetermined schedule by
depressing a plunger, and consequently the column of reagents and septa, to allow mixing of reagents
through the bypass in the glass barrel. All eight FPAs within a GAP were processed as a unit. At the
conclusion of the experimental operations, the FPAs were stored within the GAP at the prescribed
temperature. (B) FEP bags were used for the Micro-14/FEP payload, allowing for dilution (D1 and
D2 bags) and serial subculture procedures. To activate growth, yeast (1 mL, 4 × 104 cells/mL) was
injected into the first Large FEP bag (Bag A containing 11 mL YPD) and cultured for 24 h +/− 1 h at
30 ◦C. At the end of this growth stage, an aliquot was removed and diluted 20-fold (Bag AD1). From
this dilution, the next Large FEP bag was inoculated (0.25 mL into Bag B containing 11.8 mL YPD)
and cultured for 24 h +/− 1 h at 30 ◦C. This process was repeated until the cells had been cultured
for five days (through Bag E). On each of the first four days, samples were also prepared to analyze
antifungal sensitivity. For these samples, the dilution series was extended from the D1 dilution bag
to the D2 dilution bag (1:10) and aliquots (0.2 mL) from D2 were used to inoculate Small FEP bags
(A1–A12, B1–B12, etc.) containing antifungal agents or control medium (2.8 mL). Each day following
the 24 h growth period and any necessary sampling, FEP bags (Large FEP bags A–E, dilution D1 bags
A–D, and Small FEP antifungal bags) were frozen at <−80 ◦C for the remainder of the mission. (C) An
overview is provided to summarize the experimental details for each payload. Cell inoculation, time
of cultivation, relative time within the mission, and storage conditions are provided. In addition,
the outcome measurements employed for each payload are indicated. Outcome measures that
were performed/completed during flight with cells fixed in microgravity are indicated in black text.
Outcome measures that were performed using cells returned viable (chilled or frozen) and processed
post flight in the home laboratory are indicated in green text.
Table 1. Mission-specific timeline details for four separate experiments.
SpX CRS-1 SpX CRS-4 SpX CRS-16 SpX CRS-17
Micro-6 Micro-8 Micro-14/FPA Micro-14/FEP
Scrub delay (days) 0 1 1 4
Launch date 8 October 2012 21 September 2014 5 December 2018 4 May 2019
Launch to dock (h) 70.5 79.5 69.5 42
Dock to sample access (h) ˆ 79 25 30 18
Length of mission (days, launch to
splashdown) 21 35 39 31
Experiment completion toundock (h) 48 27 120 * 264 #
Splashdown to home lab (h) 70 68 84.5 66
ˆ Transition to ISS crew and power resources; * Weather related unberth delay; # Late experiments not requested.
2.3. Mission-Specific Growth Conditions and Procedures
2.3.1. Micro-6 (and the Reflight Micro-8), Space X CRS-1 and -4, Respectively
The hardware utilized for these payloads consisted of FPAs, organized eight per
Group Activation Pack (GAP) (BioServe Space Technologies). See Figure 1A for a graphic
representation of the FPA hardware and Figure 1C for an overview of the experimental
design. Each FPA was divided into 2 or 3 chambers, indicated as chamber A, B and C,
which were loaded sequentially and compartmentalized by rubber septa. Chamber A
was loaded with 2.7 mL 1.2× YPD (Sigma Aldrich, St. Louis, MO, USA), containing the
antifungal agent AmB (Sigma Aldrich, St. Louis, MO, USA) where indicated. Chamber
B was loaded with 0.5 mL C. albicans diluted in water (Low inoculum = 100 cells/mL,
High inoculum = 1 × 105 cells/mL, and are referred to as Low and High, respectively).
Chamber C contained 2.7 mL termination medium, consisting of either fixative (8.4% v/v
paraformaldehyde, Polysciences, Inc, Warrington, PA, USA) or fresh medium (1x YPD for
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samples returned live). The GAPs were maintained at a cool temperature, specifically 4 ◦C
pre-flight, ambient during launch, and 12 ◦C on the ISS, until the scheduled activation at
30 ◦C. Following the growth period (44 h for Low inoculum and 30 h for High inoculum),
GAPs were chilled to 4 ◦C and maintained at that temperature through the remainder of
the mission. There were two operational windows during the mission. Samples that were
scheduled to be fixed were activated early in the mission (referred to as Early) to avoid
any potential decreases in viability due to on-orbit storage. Conversely, cells that were
scheduled to be returned live were activated as late as possible in the mission (referred
to as Late) so as to retain viability following the growth period and during the transition
back to Earth and the home laboratory. During transport back to Earth (splashdown in
the Pacific Ocean) and then to the California-based handover location, samples were at
ambient temperature (Micro-6) or 4 ◦C (Micro-8). Following payload handover to the
Implementation Partner (BioServe Technologies) and research team, the samples were
transitioned to storage on ice until they arrived at the home laboratory. Viable samples were
isolated from the de-integrated hardware and processed the day of arrival. HOBO temperature
sensors were included in representative GAPs to retrospectively analyze the temperature
profiles and consistency between flight and terrestrial control samples (Figure 2).




Figure 2. Temperature tracings comparing the experience of flight and terrestrial control samples throughout the duration 
of the missions. HOBO temperature sensors were incorporated into selected GAPs and retrieved during hardware de-
integration at the end of the mission. (A) Samples in the Micro-6 payload that were activated early in the SpX CRS-1 
mission, (B) Samples in the Micro-8 payload that were activated and then terminated late in the SpX CRS-4 mission, and 
(C) Samples in the Micro-14/FPA payload that were activated and ‘terminated’ with fresh medium late in the SpX CRS-16 
mission for return of viable cells. Temperature sensors were not associated with FEP bag bioreactors in SpX CRS-17. Ter-
restrial control operations were performed near synchronously (2 h delay from flight) and for the purpose of this illustra-
tion the time offset was removed from the tracings to allow overlap of transitions for better comparison. Flight tempera-
tures are traced in black, terrestrial control temperatures are traced in green, and key operations are indicated in text and 
highlighted with red vertical lines. 
2.3.2. Micro-14/FPA, Space X CRS-16 
Similar to Micro-6/8, the hardware utilized for this payload consisted of FPAs orga-
nized eight per GAP (BioServe Space Technologies). This experiment also had two oper-
ational windows. Some samples were cultured as described below early in flight (Early) 
and preserved either with the addition of paraformaldehyde or by freezing until the end 
of the mission. The remaining samples were maintained at 4°C and cultured as late as 
possible in the mission (Late) and returned live and chilled (4°C) for post flight analyses 
requiring cell growth. During each operational window, cells were cultured in micrograv-
ity for 24 h +/− 1 h at 30 °C. FPAs were prepared with 2 or 3 chambers as follows. (1) 
Samples to be frozen consisted of 2 chambers: Chamber A was loaded with 5 mL of YPD 
(referred to as Low due to the lower cell concentration upon inoculation) and overlaid 
with an air bubble to promote gas exchange. Chamber B was loaded with 0.5 mL of yeast 
suspended in water (4 × 104 cells/mL). There was no chamber C. (2) Samples to be fixed 
consisted of 3 chambers: Chamber A was loaded with 2.7 mL YPD (referred to as High as 
the cell concentration was higher at the time of inoculation) and overlaid with an air bub-
ble. Chamber B was loaded with 0.5 mL of yeast suspended in water (4 × 104 cells/mL). 
Chamber C was loaded with 2.2 mL paraformaldehyde (10% v/v). (3) Samples to be re-
turned viable consisted of 3 chambers: Chamber A was loaded with 2.7 mL YPD (referred 
to as High as the cell concentration was higher at the time of inoculation) and overlaid 
with an air bubble. Chamber B was loaded with 0.5 mL of yeast suspended in water (4x104 
cells/mL). Chamber C was loaded with 2.2 mL 1xYPD. Following completion of the 
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C 
Figure 2. Temperature tracings comparing the experience of flight and terrestrial control samples
throughout the duration of the missions. HOBO temperature sensors were incorporated into selected
GAPs and retrieved during hardware de-integration at the end of the mission. (A) Samples in the
icro-6 payload that were activated early in the SpX CRS-1 mission, (B) Samples in the Micro-8
payload th t were activ ted an then ter inated late in the SpX CRS-4 mission, and (C) Samples
in the Micro-14/FPA payload that were activated and ‘terminat d’ with fresh medium late in the
SpX CRS-16 mission for return of viable cells. Temperature sensors were not associated with FEP
bag bioreactors in SpX CRS-17. Terrestrial control operations were performed near synchronously
(2 h delay from flight) and for the purpose of this illustration the time offset was removed from the
tracings to allow overlap of transitions for better comparison. Flight temperatures are traced in black,
terrestrial control temperatures are traced in green, and key operations are indicated in text and
highlighted with red vertical lines.
2.3.2. Micro-14/FPA, Space X CRS-16
Similar to Micro-6/8, the hardware utilized for this payload consisted of FPAs or-
ganized eight per GAP (BioServe Space Technologies). This experiment also had two
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operational windows. Some samples were cultured as described below early in flight
(Early) and preserved either with the addition of paraformaldehyde or by freezing until
the end of the mission. The remaining samples were maintained at 4 ◦C and cultured as
late as possible in the mission (Late) and returned live and chilled (4 ◦C) for post flight
analyses requiring cell growth. During each operational window, cells were cultured in
microgravity for 24 h +/− 1 h at 30 ◦C. FPAs were prepared with 2 or 3 chambers as follows.
(1) Samples to be frozen consisted of 2 chambers: Chamber A was loaded with 5 mL of
YPD (referred to as Low due to the lower cell concentration upon inoculation) and overlaid
with an air bubble to promote gas exchange. Chamber B was loaded with 0.5 mL of yeast
suspended in water (4 × 104 cells/mL). There was no chamber C. (2) Samples to be fixed
consisted of 3 chambers: Chamber A was loaded with 2.7 mL YPD (referred to as High
as the cell concentration was higher at the time of inoculation) and overlaid with an air
bubble. Chamber B was loaded with 0.5 mL of yeast suspended in water (4 × 104 cells/mL).
Chamber C was loaded with 2.2 mL paraformaldehyde (10% v/v). (3) Samples to be re-
turned viable consisted of 3 chambers: Chamber A was loaded with 2.7 mL YPD (referred
to as High as the cell concentration was higher at the time of inoculation) and overlaid
with an air bubble. Chamber B was loaded with 0.5 mL of yeast suspended in water
(4 × 104 cells/mL). Chamber C was loaded with 2.2 mL 1× YPD. Following completion of
the mission, the live samples were isolated from de-integrated hardware and processed the
day they arrived in the home laboratory; fixed and frozen samples were isolated shortly
thereafter. Temperature sensors were included in representative GAPs to retrospectively
analyze the operational transitions as well as consistency between flight and terrestrial
control samples (Figure 2).
2.3.3. Micro-14/FEP, Space X CRS-17
The FEP bag hardware was utilized for cultivating yeast in this payload and involved
serial passage-style growth. The parent culture (Large FEP) was serially propagated over
five days and from each of these populations a set of antifungal sensitivity cultures were
initiated (Small FEP, see Figure 1B and details in Section 2.4.3. Large FEP bags for the
parent cultures were filled with 1× YPD (11.0 mL for the initial culture, Bag A, and 11.8 mL
for the four downstream cultures, Bags B-E) and gas bubbles were removed. The yeast
inoculum of 1 mL (4 × 104 cells/mL in water) was loaded into a 3 cc syringe and sealed
for transport. The needleless syringe was used to inoculate the initial culture (11 mL FEP
bag, Bag A) on orbit. Following 24 h of growth at 30 ◦C, 0.5 mL of culture was removed
from Bag A and diluted 20-fold in water (D1 FEP bags). An aliquot of this diluted sample
(0.25 mL) was used to inoculate the next Large FEP bag (11.8 mL YPD, Bag B). This process
was repeated such that the yeast was continually propagated through five cycles of 24 h
growth (Bags C, D and E). The Large FEP bag samples were frozen (<−80 ◦C) either in the
presence (Bag A and E) or absence (Bags B–D) of glycerol as a cryopreservation agent. As a
complement to this series of growth, Small FEP bags containing 2.8 mL YPD and antifungal
agents as indicated (AmB, 0.12–5 mg/L; and CAS, 0.01–0.1 mg/L) were inoculated with a
dilution of the corresponding Large FEP culture. Specifically, the 20-fold dilution prepared
from the large FEP bag as described above (D1) was further diluted 10-fold (D2 FEP bag)
and aliquots (0.2 mL) were used to inoculate each Small FEP bag (A1–12 from FEP Bag A;
B1–12 from FEP Bag B, etc.). These cultures were grown at 30 ◦C for 24 h and then frozen
at <−80 ◦C for the duration of the mission. At the end of the mission, frozen samples
were maintained at <−25 ◦C from undocking to the California-based handover location
using phase change bags (Cold Stowage, NASA, Houston, TX, USA) and then to the home
laboratory using dry ice.
2.4. Ground-Based Analyses
2.4.1. Cell Growth and Morphology
Cells were fixed with paraformaldehyde (4% v/v, final) either in flight or immediately
following hardware de-integration post flight. Direct manual cell counts were performed
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in duplicate using a Bright-Line hemocytometer (Sigma Aldrich) quantifying total cells as
well as the contribution of cells with an extended morphology (filamentation; length greater
than 2× the width of the cell) to the population. Samples were also stained with Calcofluor
White (25 µM final, Molecular Probes) to stain chitin in the yeast cell wall and visualized
using epifluorescence microscopy. Cell diameter and filament length were recorded using
image collection on a Nikon Eclipse E-800 and interpreted using the software program
Metamorph.
Samples of non-fixed cultures were cultured post-flight on YPD agar plates as an
indication of viability. Viability was calculated using colony forming units (CFU) with the
actual/observed number of colonies compared to that expected based on cell counts. It is
important to note that cell viability is likely to be higher than interpreted from the CFU
analyses included in these studies due to the convention of our cell counting; budding
cells are counted as two cells since that is how they will likely contribute to growth in
planktonic cultures, whereas, these cells may remain associated during the plating process
and give rise to a single colony. With this in mind, it should be understood that post-flight
cell viability was quite high.
2.4.2. Biofilm formation
Previous studies demonstrated that C. albicans formed biofilm communities on the
siliconized rubber membrane component of HARV bioreactors [31,39]. For this reason,
small (5 mm2) samples of this membrane (Synthecon, Houston, TX, USA) were included in
chamber A of select FPAs in Micro-6 and Micro-14/FPA. Samples were fixed during the
mission and analyzed upon return. Upon hardware de-integration, the membrane coupons
were placed into individual wells of a 24-well plate and stained with Crystal Violet (0.4%
w/v in water, 1 mL per well, Sigma Aldrich) to stain cells and cell matrix components,
adapted from previous methods [40]. Excess stain was aspirated, 1mL water was added to
each well and mixed thoroughly. From each well, 100 µL was transferred to a 96-well plate
to record optical density (referred to as ‘stain’). Excess water was removed from each well
and discarded. A fresh aliquot of sterile water (1 mL) was added to each well, mixed, and a
100 µL sample was transferred to the 96-well plate (wash 1). Membranes were subjected to
two more rounds of water washes and a final extraction with 1 mL of 10% v/v acetic acid
(aa wash) to remove residual organic material, each involving transfer of a 100 µL aliquot
to the 96-well plate (referred to as wash 2, wash 3, and aa wash, respectively). Stain levels
were quantified on a microplate reader at 595 nm (iMark, BioRad, Hercules, CA, USA).
2.4.3. Antimicrobial Resistance
The susceptibility of C. albicans to antifungal agents was determined by the ability
of cells to grow in the presence of the indicated drug. Cells were either cultured in the
presence of antifungal agents during the mission and preserved by fixation or freezing,
or following the flight, live yeast was exposed to the antifungal agents immediately after
recovery from the hardware. In the former case, the growth medium was supplemented
with the antifungal agent in the hardware and maintained at 4 ◦C to retain drug efficacy into
the mission timeline. Following the 24 h growth period, samples were fixed as indicated
in the Mission-Specific details. Susceptibility was determined by direct cell count and the
results were compared to samples without drug, as well as to the corresponding terrestrial
controls. Alternatively, yeast cells were cultured in microgravity without treatment and
returned live. Viable cells were recovered from the de-integrated hardware, counted,
diluted to 1 × 105 cells/mL, and added (100 µL) in triplicate to wells of a 96-well plate
pre-loaded with 100 µL control medium (2× YPD) or antifungal agent (2×) in YPD. The
plates were incubated at 30 ◦C for 24 h and 72 h and cell growth was quantified by optical
density at 595 nm (iMark, BioRad, Hercules, CA, USA). The drug concentrations chosen to
assess AmB and CAS sensitivity were identified in the literature and refined empirically
based on dose sensitivity assays performed with the Candida isolate used in the laboratory
(unpublished data and [31,41–44]).
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2.4.4. Statistical Analysis
For all data sets, means +/− standard deviations are shown. Determination of the
difference between mean values for each data set was assessed by Student t-test. Signifi-
cance testing comparisons are described in the associated figure legends and are routinely
provided as flight compared to terrestrial controls, antifungal agent to control, or between
hardware types. Significance was established at p values <0.05, with more specific p values
provided in the corresponding figure legends.
3. Results
3.1. Mission Timelines
Although each mission has different timing, the specifics of which change in real time
based on the actual launch date and accompanying mission scenario, Table 1 summarizes
our general experiences for each payload. Categories in this table were chosen to provide
perspective and demonstrate the temporal opportunities and constraints in which experi-
ments are conducted. Understanding the launch cancelation (scrub) and subsequent launch
scenarios (Scrub delay and Launch date) establishes the prelaunch experiment planning and
preparation, especially as they relate to sensitive reagents and cells that have longevity
and storage considerations. Launch to dock (arrival at the ISS) and Dock to sample access
represent times during which samples are largely inaccessible for processing, although
temperature requirements can often be maintained even with non-powered payloads. The
lapse of time between when the vehicle docks and when the crew accesses specific samples
may be important for an experiment, but occurs during a busy time of the mission. As
such the timing for sample transfer to on-orbit power-controlled environments or early
initiation of experimental procedures are negotiable, but ultimately needs to fit within the
crew schedule, competing requests, and mission priorities. The Length of mission illustrates
the active duration of the on-orbit procedures during which experiments can be conducted,
including the shoulder days necessary for vehicle unpacking (beginning of the mission)
and packing (end of the mission), during which crew time may be limited. Of note, samples
often need to be equilibrated to a particular storage/post-mission temperature for travel
once the experimental procedures are complete. One-to-two days is typically allowed for
this temperature transition before packing the samples into the return vehicle (Experiment
completion to undock). Finally, from the time the vehicle splashes down to when the samples
arrive at the home laboratory, Splashdown to home lab, is relevant for sample processing
considerations. These timelines will vary based on the splashdown location, travel time
to shore, requirements of the science, and individual opportunities. In total, the timeline
data is presented to provide some perspective as to how to prepare for and maximize the
success of a spaceflight experiment using the ISS.
3.2. Sample Temperature Transitions throughout Mission
Our first flight experiment was transported to the ISS on SpX CRS-1, so we were eager
to obtain as much tracking information as possible, especially since there was no historical
data on which to depend. In order to evaluate whether samples were exposed to the
expected temperatures and to compare ambient temperatures within the ISS to those of the
terrestrial setting of our laboratory, HOBO temperature sensors were included in selected
GAPs. Figure 2 provides representative temperature tracings for flight and corresponding
terrestrial controls for the duration of the indicated mission. Examples from SpX CRS-1
(Figure 2A), -4 (Figure 2B) and -16 (Figure 2C) are included. SpX CRS-17 utilized FEP bags
and thus did not accommodate an accompanying temperature sensor. As illustrated in
each panel, the active aspects of the experimental procedures were well aligned between
the flight (black lines) and terrestrial controls (green lines) in terms of time and temperature
(see activation and termination indicators on tracings, labeled and indicated by red vertical
lines). The time offset (usually 2 h) between flight and terrestrial experimental procedures,
which is necessary to verify on-orbit procedures by the crew, was removed to improve
the temperature comparisons between conditions. Although the mid-mission storage
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temperatures varied slightly, with terrestrial controls elevated 1–2 ◦C relative to flight in
SpX CRS-1 (Figure 2A) and reduced by approximately 7 ◦C in SpX CRS-16 (Figure 2C),
the sample quality was likely to be minimally affected because the temperature variance
was during stasis or after the operational window of the experiment. Of concern though,
was the elevated temperatures of the SpX CRS-1 flight samples following undocking
(approaching 25 ◦C) since the elevated temperature would promote post-microgravity
growth of samples being returned live. Other than that specific situation, the temperatures
of terrestrial samples were well-aligned with flight samples and the temperature targets
were well approximated.
3.3. Yeast Growth
At the time the initial studies were designed and initiated in 2011, one priority was
to determine whether microgravity influenced overall cell growth. Although a simple
outcome measure, growth was an important consideration for yeast as a potential infectious
risk in spaceflight, but also provided insight into yeast adaptation to the microgravity
environment. Embedded within the growth studies was a plan to allow the yeast to grow
in microgravity for as long as possible, in spite of the requirement for a sealed growth
chamber to ensure crew safety in the presence of an opportunistic pathogen. As such, the
FPA bioreactors were prepared with two concentrations of yeast; a high inoculum (High,
1 × 105 cells/mL) to ensure growth, and a low inoculum (Low, 100 cells/mL) to allow
maximum replicative potential before stationary phase was reached. The protocol was also
designed such that yeast growth was activated early (Early) in the mission to minimize any
potential storage stress on the cells while maintained in water-induced stasis. In addition,
comparable samples were stored and activated late (Late) in the mission so that cells could
also be returned live for post-mission analyses. This design also allowed some comparison
between cells activated Early and Late in the mission to evaluate the effects of storage in
the microgravity environment. As seen in Figure 3A, cell growth in most of the samples
peaked at ~1 × 106 cells/mL, although the Low inoculum samples activated Early in the
mission (Early Low) grew to a slightly higher density and demonstrated a minor advantage
to cells grown in microgravity (Early Low, * p = 0.02).
It is worth noting that in Micro-6, cells that were scheduled to be returned live and stored
at 4 ◦C actually experienced a 3-day transport temperature of nearly 25 ◦C (Figure 2). The
cell growth data in Figure 3A for viable samples (‘Viable Low’ and ‘Viable High’) suggest
that the cells indeed continued to grow. The higher level of growth in the flight samples
as compared to terrestrial controls likely reflects the elevated temperature during trans-
port. There was not a mechanism to track temperatures in real-time in order to subject
terrestrial controls samples to conditions comparable to that experienced by the flight
samples. Interestingly, the additional growth of the viable samples in both microgravity
and terrestrial conditions indicates that the culture environment was capable of supporting
at least 1–2 additional doublings, thus other factors must have been contributing to the
apparent growth cap (1 × 106 cells/mL) observed in the other Micro-6 samples (Figure 3A).
For clarity, the on-orbit growth period was sufficiently long for the Low inoculum samples
to reach a density of 6 × 107 cells/mL and the High inoculum samples to reach a density
of >1 × 108 cells/mL, using generation times established in ground-based studies.
As seen in Table 2, generation times were calculated, factoring in the differences in
inoculum size, and found to be similar between flight samples and the terrestrial controls.
Interestingly, samples with the High cell inoculum had much longer generation times
(300+ min/generation as compared to 150+ min/generation), suggesting the cell density
of 1 × 106 cells/mL was reached and the culture likely went into stationary phase. A
kinetic analysis of cell growth was not performed due to resource constraints and safety
precautions, so temporal aspects of the yeast growth dynamics cannot be concluded from
these studies.
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ission co parison using the same hardware (FPA comparison between A,B), as well as comparison using two different
types of spaceflight hardware (A/B = FPAs ver us C = FEP bags). ‘Low’ refers to the samples seed with a low inoculum,
‘High’ refers to samples seeded with a high inoculum, ‘Early’ refers to samples activated ne r the beginnin of the spaceflight
mission, ‘Late’ refers to samples activated late in the spaceflight mission, and ‘viable’ refers to samples returned alive.
Differential growth was not noted in the viable samples since flight cells were subjected to different transport temperatures
than the terrestrial controls. Large FEP bags represent those with a final volume of 12 mL; small FEP bags represent those
with a final volume of 3 mL. Black bars = flight; green bars = terrestrial controls. * p = 0.02; ** p = 0.01.
Table 2. Gener tion tim of yeast cells cultu d in sp c flight and terres rial cont ol bioreactors.
Sample Flight-Generation Time (min) Ground-Generation Time (min)
FPA-Early Low (Micro-6) 155 159
FPA-Early High (Micro-6) 303 303
FPA-Late Low (Micro-6) 163 163
FPA-Late High (Micro-6) 300 310
FPA-Low (Micro-14/FPA) 113 129
FPA-High (Micro-14/FPA) 127 126
FEP-Large (Micro-14/FEP) 95 99
FEP-Small (Micro-14/FEP) 113 118
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In the Micro-14 experiments, yeast grew to a 10-fold higher cell density than in the
Micro-6 payload, even though they both used the FPA hardware (Table 2, Figure 3B).
As indicated in Table 2, the generation times were similar among the Micro-14/FPAs,
regardless of the initial cell concentration. Due to the similarity in growth characteristics
of the Low and High inoculum samples in the Micro-14/FPA payload, the data were
aggregated for Figure 3B. In this case, there is a trend toward an increased cell density of
cells cultivated in microgravity.
Finally, yeast cells grew most robustly when cultured in the FEP bag bioreactor (Table 2,
Figure 3C) both in terms of shortest generation times and highest cell density. Indeed,
the cell density observed in the FEP bags resembles that obtained with ground-based
shaker cultures (2–3 × 108 cells/mL). For comparison, activation occurred at approxi-
mately 4100 cells/mL in the Large FEP bags (parent cultures for the serial cultivation)
and approximately 33,300 cells/mL in the Small FEP bags (medium-only control bags
from the antifungal drug study). These inoculations were the result of serial dilutions and
inoculation done by flight crew (and corresponding ground crew), so cell concentrations
are predicted. The cells within the Large FEP bags likely did not reach maximal density
due to the length of the growth period, which in hindsight could have been extended
another couple of hours. Data obtained from the small FEP bags in this payload indicates
that C. albicans grows to a higher density in microgravity than in the terrestrial controls
(** p = 0.01). Cumulatively, there was a trend in each of the payloads and in two types of
hardware suggesting yeast grows to a higher cell density in microgravity than in terrestrial
control conditions.
3.4. Biofilm Formation
Biofilm formation is an important adaptation for cells facing environmental stress
and our previous studies indicated that biofilm communities formed on the siliconized
rubber membranes in HARV bioreactors [31]. As such, small coupons of this material
were included in select FPAs in the Micro-6 and Micro-14 payloads to determine whether
C. albicans would colonize the substrate de novo during short duration growth. During
post-mission analyses, colonies could not be identified by microscopy in either experiment.
The membrane coupons included in Micro-14/FPAs were fixed during flight and upon
return they were subjected to a staining and washing procedure that is designed to identify
cells, cellular debris, and/or cell-deposited matrix attached to the membrane substrate.
From published studies, the more resistant the stain is to removal by washing, the tighter
the association is between the stained material (cell community and components thereof)
and the substrate [40]. Although a small and preliminary experiment, Figure 4 indicates
that there does not seem to be an advantage for cells to form biofilms on the membrane
coupons under the conditions in which they were grown. It is important to note that these
were 24 h growth studies and it may take longer for the yeast to form cellular communities,
especially if the substrate is not specifically inoculated. Indeed, the terrestrial control
membranes appeared to be more apt to retain stained cellular components than in the flight
samples, perhaps due to gravity-induced sedimentation (green line). In contrast, yeast
was retained to a greater extent on the membrane coupons of cultures grown in hypoxic
conditions in microgravity than comparable terrestrial controls (manuscript in preparation).
Longer term studies, with cells under a variety of conditions, will be required to fully
understand biofilm formation in the microgravity environment.
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ing terrestrial control samples. A more thorough analysis of each payload found substan-
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tous morphology (Figure 5A). Interestingly, although the overall level of filamented cells 
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Figure 4. Passive seeding of biofilm communities on siliconized rubber membrane coupons. Sili-
conized rubber membrane coupons were included in the medium (chamber A) of selected FPAs in
Micro-14/FPA and allowed to freely seed during the 24 h growth period of the experiment. Samples
were fixed in microgravity and follo ing sample return and h rdwar de-integ ation, the mem-
branes were recovered and stained with Crystal Violet as an indicator of cells, cellular debris, and
extracellular matrix. Stain that is retained on the membrane through a series of three water washing
steps (wash 1, 2 and 3) and a final acetic acid wash (aa wash) is suggestive of a tighter integration
of the cells with the substrate material. The stain removed by each wash was quantified by optical
density at 595 nm. Bl ck line = flight; green line = terrestrial control.
3.5. Cell Morphology and Filamentation
The propensity of C. albicans to form filaments when confronted with environmen-
t l stresses, and the association of this morp ology with incre s virulence, led us to
evaluate size and shape as firs line analyses to determine whether and how the yeast
adapt to a novel environment. Indeed, we and others have demonstrated differences in
cell size, cell cl mpi g, and filamentation of C. albicans cultivated in simulated or true
microgravity [29,35,36,45]. Initial analyses of the Micro-6 payload suggested that more of
the samples cultured in microgravity contained filamented cells than did the corresponding
terrestrial control samples. A more thorough analysis of each payload found substantial
variability, but did not support the hypothesis that microgravity stimulates a filamentous
morphology (Figure 5A). Interestingly, although the overall level of filamented cells was
low in each of the payloads, cells cultured in FEP bags had a significantly lower level of fil-
amented cells than those in FPAs, regardless of whether they were cultured in microgravity
or on Earth (Figure 5A). Cell size as also variable, with large cells measuring over 7.5 µm
and smaller c lls measuring 3.1 µm, althoug the average siz of yeast form cells was not
signific n ly different between flight (4.8 µm) and terrestrial controls (4.6 µm). Filaments
were observed within the populations, whether cultivated in microgravity or terrestrially,
with some filaments reaching lengths of over 142 µm (Figure 5C). In contrast to previous
studies [28,35], cell clumping was not observed.
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3.6. Characteristics of C. albicans Cultured Post Flight 
Many outcome measures can be obtained from experiments conducted to completion 
on the ISS, yet for reasons of feasibility (especially working with a potential pathogen), as 
well as sample access and efficient use of crew time, we were interested in determining 
whether samples could be cultured in microgravity, returned live, and assessed immedi-
ately upon return with ground-based procedures. As preliminary evidence from the data 
obtained on SpX CRS-1 and presented in Figure 3A, it was clear that yeast transitioned to 
4 °C following the growth period in microgravity remained viable and were capable of 
continued growth. In those studies, viable samples from the Micro-6 payload were sched-
uled to be returned at 4 °C, but the unavailability of cold storage resulted in transition to 
ambient temperature, as illustrated in Figure 2A. The yeast continued to grow during 
transport as observed in Figure 3A (‘Viable Low’ and ‘Viable High’). In retrospect, it was 
determined that flight samples were maintained at approximately 5 °C higher than terres-
trial controls for nearly three days, likely contributing to the relative higher growth ob-
served in the flight samples.  
As a quantitative analysis of post-flight viability, yeast cells were plated to evaluate 
colony forming units (CFU) relative to that expected based on direct cell counts. As illus-
trated in Figure 6A, the colony forming potential, and thus cell viability, following the 
Micro-6 mission was similar between flight and terrestrial controls, regardless of inocu-
lum concentration. Interestingly, when the same analysis was performed on samples in 
the Micro-14/FPA payload, with transport temperatures maintained at <6 °C, terrestrial 
controls had a rate of viability double that of samples cultured in microgravity (Figure 
6B). CFU analysis was also performed on yeast that were cryopreserved (5% glycerol) 
during the Micro-14/FEP mission. As observed in Figure 6C, the viability of cryopreserved 
yeast following propagation in microgravity is comparable to that of terrestrial controls. 
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in the three payloads were fixed and retained at 4 ◦C for microscopic analyses. Some samples were
fixed in microgravity, but for those samples returned frozen or viable, the aliquot was fixed imme-
diately upon sample return to the home laboratory. (A) Filaments were quantified as a percentage
of the total population. In this analysis, samples were aggregated by hardware, thus the FPA data
represents samples cultured in YPD from the Micro-6 and Micro-14/FPA payloads. Similarly, the
FEP data represents the aggregate from samples cultured in YPD in Large FEP bags and Small
FEP bags from the Micro-14/FEP payload. * p < 0.003 for FPA vs. FEP. (B–E) Calcofluor White
stained cells were visualized to evaluate cell morphology from Micro-14/FPA, scale bar = 35 µm;
(B,C) are from terrestrial control samples and (D,E) are from flight samples. The arrows highlight
key features in each of the images, including, (B) a cell with a bud scar, as indicated by a cell surface
region with higher intensity staining and a second cell with a caliper measurement of 5.1 µm, (C) a
caliper measured filament (142 µm) in which higher intensity staining also indicates intercellular
septa (arrow), (D) cells in the process of budding (arrow), and (E) long filamentous cell demarcated
with narrowed septal junctions (top arrow), a cell budding from the filament (middle arrow), and
increased staining at septal junctions (bottom arrow).
3.6. Characteristics of C. albicans Cultured Post Flight
Many outcome measures can be obtained from experiments conducted to completion
on the ISS, yet for reasons of feasibility (especially working with a potential pathogen), as
well as sample access and efficient use of crew time, we were interested in determining
whether samples could be cultured in microgravity, returned live, and assessed immediately
upon return with ground-based procedures. As preliminary evidence from the data
obtained on SpX CRS-1 and presented in Figure 3A, it was clear that yeast transitioned
to 4 ◦C following the growth period in microgravity remained viable and were capable
of continued growth. In those studies, viable samples from the Micro-6 payload were
scheduled to be returned at 4 ◦C, but the unavailability of cold storage resulted in transition
to ambient temperature, as illustrated in Figure 2A. The yeast continued to grow during
transport as observed in Figure 3A (‘Viable Low’ and ‘Viable High’). In retrospect, it
was determined that flight samples were maintained at approximately 5 ◦C higher than
terrestrial controls for nearly three days, likely contributing to the relative higher growth
observed in the flight samples.
As a quantitative analysis of post-flight viability, yeast cells were plated to evaluate
colony forming units (CFU) relative to that expected based on direct cell counts. As illus-
trated in Figure 6A, the colony forming potential, and thus cell viability, following the
Micro-6 mission was similar between flight and terrestrial controls, regardless of inoculum
concentration. Interestingly, when the same analysis was performed on samples in the Micro-
14/FPA payload, with transport temperatures maintained at <6 ◦C, terrestrial controls had a
rate of viability double that of samples cultured in microgravity (Figure 6B). CFU analysis was
also performed on yeast that were cryopreserved (5% glycerol) during the Micro-14/FEP
mission. As observed in Figure 6C, the viability of cryopreserved yeast following propaga-
tion in microgravity is comparable to that of terrestrial controls. Although cryopreservation
is a well-documented mechanism to maintain viability, pre-flight ground-based studies
indicated that C. albicans is surprisingly hardy when frozen in the absence of a cryopreserva-
tion agent. Non-flight associated, ground-based studies demonstrated that although there
is a rapid reduction in viability of cells stored at −80 ◦C, 50% of cells survive when frozen
for 50 days, and 30% survive frozen for 100 days when compared to cells stored for the
same amount of time in 5% glycerol (unpublished data). Considering this resiliency, cells
frozen in microgravity without cryopreservation in Micro-14/FEP (Small FEP bags) were
plated to determine viability. Surprisingly, yeast cultured in microgravity were remarkably
more susceptible to freeze damage in the absence of a cryopreservation agent than were
the terrestrial controls (Figure 6D). Similarly, flight samples frozen without cryopreser-
vation in Micro-14/FPA also had a 5.9- to 10-fold lower viability (as per CFU) than did
the terrestrial samples (data not shown). The discrepancy of survival between flight and
control samples observed in these studies is intriguing. Due to reduced convection, the
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samples in microgravity are likely to freeze at a slower rate than terrestrial controls, yet a
slower rate of freezing is often associated with improved cell viability [46,47]. Thus, the
freezing rate is not likely to explain the difference in survival between microgravity and
terrestrial cells. Indeed, ground-based studies comparing fast and slow freezing rates did
not result in differences in yeast viability (data not shown). In addition, since the cells in
Figure 6D were frozen for the return trip to Earth, it seems unlikely that re-entry g-force would
have much impact on cell viability. Cumulatively, the diminished post-flight survival of cells
cultivated in microgravity and stored either chilled (Figure 6B) or frozen without cryopreser-
vation (Figure 6D) may suggest cellular adaptations that compromise cell wall or plasma
membrane integrity. Current studies are underway evaluating changes in ergosterol, the
membrane-associated yeast lipid comparable to cholesterol, levels in microgravity.
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viability. Surprisingly, yeast cultured in microgravity were remarkably more susceptible 
to freeze damage in the absence of a cryopreservation agent than were the terrestrial 
controls (Figure 6D). Similarly, flight samples frozen without cryopreservation in Micro-
14/FPA also had a 5.9- to 10-fold lower viability (as per CFU) than did the terrestrial 
samples (data not shown). The discrepancy of survival between flight and control samples 
observed in these studies is intriguing. Due to reduced convection, the samples in 
microgravity are likely to freeze at a slower rate than terrestrial controls, yet a slower rate 
of freezing is often associated with improved cell viability [46,47]. Thus, the freezing rate 
is not likely to explain the difference in survival between microgravity and terrestrial cells. 
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Figure 6. Viability of yeast cells stored chilled or frozen. At the conclusion f the growth perio
during the mission, cells were chilled to 4 ◦C (A) Micro-6 and (B) Micro-14/FPA. Alternatively, cells
were frozen at <−80 ◦C and transported to Earth at <−25 ◦C with (C) glycerol as a cryopreservation
agent in Micro-14/FEP, Large FEP bags or (D) without glycerol in Micro-14/FEP, Small FEP bags.
Following sample return and hardware de-i egration, cells were imm diately isolated, counted,
diluted, and plated to quantify colony formation. Colonies were counted after 3 days of growth at
30 ◦C. Data is represented as the actual number of colonies relative to that expected based on cell
counts. Panel A represents samples activated late in the mission (Late) with either the high inoculum
(High) or low inoculum (Low), as previously described. Black bars = flight; green bars = terrestrial
controls. * p < 0.03, ** p = 0.003, flight vs. terrestrial.
In addition to quantifying colony numbers, macro-arch te tur of the colonies was
also evaluated. We previously demonstrated that colonies initiated from cells cultured
in analog conditions, specifically the ground-based HARV bioreactors, de onstrated
a complex and relatively unique morphology referred to as highly irregular wrinkled
(HIW) [31]. These colonies also consisted of a high percentage of filamentous cells. We
were eager to evaluate whether similar macrostructure was produced from cells cultured in
microgravity. As illustrated in Figure 7 (panels A–F), the predominating colony morphology
was smooth with agar-invading spike-like projections and larger offshoots, referred to
as ‘feet’ projections in the literature [48,49]. This colony structure did not vary between
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flight samples (Figure 7A,C,E) and corresponding terrestrial controls (Figure 7B,D,F) in the
Micro 6 (Figure 7A,B) or Micro 14/FPA (Figure 7C–E) payloads. The observed morphology
was not representative of the fully smooth structure commonly associated with terrestrial
cultures of C. albicans [50] nor to the HIW colonies observed almost exclusively from
cells cultured in the HARV (Figure 7H) [31]. The observed spikey morphology seems to
be specific to cells cultured in FPAs, as those grown in the FEP bags (Figure 7G) were
predominantly smooth, with some colonies harboring the more traditional ‘feet’ projections
often attributed to elevated CO2 conditions [48,49].




Figure 7. Colony morphology and size evaluated in yeast samples returned live. Following each 
mission, cells were isolated immediately following hardware de-integration, counted, diluted, and 
spread on YPD agar plates. Following 3 days of growth at 30 °C the plates were transferred to 4 °C 
pending analysis. (A–H) Individual colonies were imaged to evaluate colony architecture. A, C, E, 
G represent flight samples; B, D, F represent terrestrial controls; H represents the HIW colonies 
produced after cultivation in the ground-based HARV bioreactor. Specifically, colonies are associ-
ated with the following payloads (A, B) Micro-6; (C,D) Micro 14/FPA, view of top of colony; (E, F) 
Micro 14/FPA, view of bottom of colony; (G) Micro-14/FEP and (H) HIW colony from HARV bio-
reactor as a morphology reference. Scale bars in panels A, B = 2.25 mm, C–F = 1 mm, G, H = 2 mm. 
(I) The diameter was measured on each of 15 colonies per plate for each payload. An aggregate of 
the data from all payloads was pooled and indicated as ‘All’. Black bars = flight; green bars = ter-
restrial controls. *p < 0.001, flight vs. terrestrial. 
3.7. Susceptibility to Antifungal Agents 
As an opportunistic pathogen, the susceptibility of C. albicans to antifungal agents is 
an important consideration with regard to spaceflight crew safety. This becomes even 
more critical based on our previous findings that yeast cultured in analog bioreactors 
(HARV) have an increased resistance to AmB [31]. As such, the ability of C. albicans to 
grow in the presence of two antifungal agents (AmB and CAS) was evaluated both by 
treating cells during the mission while in microgravity, as well as on yeast returned live 
following the conclusion of the flight. The Micro-6 payload was specifically designed to 
evaluate yeast growth in the presence of AmB while in microgravity. Cell growth was 
activated by the addition of medium containing 0.12 mg/L and 0.25 mg/L AmB and the 
samples were fixed following the growth period. Upon conclusion of the mission cell 
counts were performed to indicate the susceptibility of C. albicans to the cytotoxic effects 
of the antifungal agent (Figure 8A). AmB susceptibility was also evaluated in cells re-
turned viable and exposed to drug following the mission, using CFU as the viability indi-
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7. Colony morphology and size evaluated in yeast sampl s returned live. Following each
ission, cells were isolated immediately following hardware de-integration, counted, diluted, and
spread on YPD agar plates. Following 3 days of growth at 30 ◦C the plates were transferred to
4 ◦C pending analysis. (A–H) Individual colonies were imaged to evaluate colony architecture.
(A,C,E,G) represent flight samples; (B,D,F) represent terrestrial ontrols; H repre ents the HIW
colonies produced after cultivation in the ground-based HARV bioreactor. Specifically, colonies
are associated with the following payloads (A,B) Micro-6; (C,D) Micro 14/FPA, view of top of
colony; (E,F) Micro 14/FPA, view of bottom of colony; (G) Micro-14/FEP and (H) HIW colony from
HARV bioreactor as a morphology reference. Scale bars in panels (A,B) = 2.25 mm, (C–F) = 1 mm,
(G,H) = 2 mm. (I) The diameter was measured on each of 15 colonies per plate for each payload. An
aggregate of the data from all payloads was pooled and indicated as ‘All’. Black bars = flight; green
bars = terrestrial controls. * p < 0.001, flight vs. terrestrial.
Whether cells p oduced colonies, and how many, a used to evaluate cell viability as
previously described and demonstrated in Figure 6. In additio , the size (diameter in mm)
of individual colonies was measured as an indirect indicator of cell health and vigor. The
diameter was measured on an average of 15 isolated colonies when possible (there were
not that many colonies produced from the non-cryopreserved cells from Micro-14/FEP,
Figure 6D). As illustrated in Figure 7I, there was an overall trend for cells cultured in flight
to give rise to slightly larger colonies. In conjunction with the yeast growth presented in
Figure 3, this is another outcome measure that indicates cells may gain a growth advantage
upon exposure to icrogravity as compared to terrestrial controls. In addition, the growth
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advantage appears to be retained for at least a few days following re-introduction to Earth’s
gravity environment. Colonies derived from cells harvested from FPAs (Micro-6 and Micro-
14/FPA) were similar in size to those harvested from FEP bags (Micro-14/FEP) suggesting
the hardware was not introducing differences in growth potential.
3.7. Susceptibility to Antifungal Agents
As an opportunistic pathogen, the susceptibility of C. albicans to antifungal agents is
an important consideration with regard to spaceflight crew safety. This becomes even more
critical based on our previous findings that yeast cultured in analog bioreactors (HARV)
have an increased resistance to AmB [31]. As such, the ability of C. albicans to grow in the
presence of two antifungal agents (AmB and CAS) was evaluated both by treating cells
during the mission while in microgravity, as well as on yeast returned live following the
conclusion of the flight. The Micro-6 payload was specifically designed to evaluate yeast
growth in the presence of AmB while in microgravity. Cell growth was activated by the
addition of medium containing 0.12 mg/L and 0.25 mg/L AmB and the samples were fixed
following the growth period. Upon conclusion of the mission cell counts were performed
to indicate the susceptibility of C. albicans to the cytotoxic effects of the antifungal agent
(Figure 8A). AmB susceptibility was also evaluated in cells returned viable and exposed
to drug following the mission, using CFU as the viability indicator. Interestingly, the
AmB susceptibility results from the Micro-6 payload were nearly identical, regardless of
whether drug exposure was in microgravity (Figure 8A) or following post-flight cultivation
(Figure 8B). Although both doses of AmB impacted yeast growth, flight cells were more
resilient than terrestrial control cells in the presence of the highest dose of AmB (0.25 mg/L).
The Micro-14/FEP payload was also designed to evaluate antifungal sensitivity in micro-
gravity. Parent cultures were serially passaged as described in Methods. On two separate
occasions during the serial growth (following day 1 and 3 for AmB or day 2 and 4 for CAS),
a dilution of the Large FEP bag culture was used to inoculate Small FEP bags containing
antifungal agents (see Figure 1 for experimental design details). On each of the four days
of the analysis, yeast were also cultured in control medium and 0.25 mg/L AmB for a
direct day-to-day comparison. There was not a notable day-to-day adaptation of yeast to
the antifungal agents (data not shown); therefore, samples conducted on the two separate
days were treated as replicates and grouped in the analyses described herein. Throughout
these studies, there was a consistent trend for the cells cultured without drug to grow to a
higher density in flight as compared to terrestrial controls, as demonstrated in Figure 3. In
addition, and as illustrated in Figure 8C/D, cells grew to a higher density in all conditions
of the FEP payload when compared to Micro-6 FPA samples. Cultures propagated in
microgravity were consistently more resistant to AmB than comparable terrestrial controls
(p < 0.006). As illustrated in Figure 8C, flight samples grew in the presence of AmB when
compared to untreated flight samples (p < 0.05), whereas the growth of terrestrial samples
was stagnated in the presence of the antifungal agent when compared to the untreated
ground controls (p > 0.33). As such, cells cultured in microgravity were more resistant
to all doses of AmB than were the corresponding terrestrial control cells (p < 0.002). In
contrast, companion cultures in the Micro-14/FEP payload that were exposed to a func-
tionally distinct antifungal agent, CAS, were susceptible to increasing concentrations of
drug, (Figure 8D). When CAS-treated samples were compared to the corresponding control
cultures (flight CAS vs. flight YPD; terrestrial CAS vs. terrestrial YPD), the lowest dose had
very little impact on cell growth and the highest dose prevented nearly all growth. Only
at the intermediate dose of CAS (0.025 mg/L) was there an apparent difference between
the impact of the drug on cells cultivated in flight or terrestrially. When compared to the
untreated samples, terrestrial controls were more resistant to CAS than the cells cultured
in microgravity, although not to the level of significance. Consequently, the resistance to
AmB does not appear to indicate a broad spectrum resistance to antifungal agents and thus,
the resistance to AmB may help elucidate the molecular and cellular adaptations that are
occurring in microgravity.
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counts performed upon return, (B) Untreated Micro-6 cells that were activated Late in the mission and returned viable 
were analyzed for antifungal sensitivity (AmB) at the conclusion of the mission using CFU analysis following drug expo-
sure. Micro-14/FEP samples were cultured in the presence of (C) AmB at 0.12 mg/L, 0.25 mg/L, and 0.5 mg/L AmB and 
control conditions (YPD + DMSO) or (D) CAS at 0.01 mg/L, 0.025 mg/L and 0.1 mg/L CAS and control conditions, frozen 
on-orbit, and cell counts were completed following the mission. * p < 0.05, ** p < 0.006, Flight vs. Terrestrial (A, B); treated 
vs. sham (C, D). 
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As increasing numbers of people spend longer amounts of time in space, it is imper-
ative to understand the physiological adaptations that humans may experience as well as 
the threats they may encounter. C. albicans is important in its own right as an opportunistic 
pathogen, but as a eukaryotic organism, it may also provide a simple system that affords 
insight into how more complex eukaryotes respond to the environment of microgravity. 
That said, a thorough and robust investigation of biological adaptation to microgravity is 
complicated for a variety of reasons. Importantly, microgravity cannot be replicated on 
Earth. Devices that have been developed as simulation bioreactors have not been fully 
evaluated to determine which aspects of microgravity they simulate, nor the reliability 
and predictive value they provide. Secondly, opportunities to conduct experiments in true 
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0.12 mg/L and 0.25 mg/L AmB and co trol conditions (YPD + DMSO), fixed at the end of the growth period, and cell
counts performed upon return, (B) Untreated Micro-6 cells that were activated Late in the mission and returned viable were
analyzed for antifungal sensitivity (AmB) at the conclusion of the mission using CFU analysis following drug exposure.
Micro-14/FEP samples were cultured in the presence of (C) AmB at 0.12 mg/L, 0.25 mg/L, and 0.5 mg/L AmB and control
conditions (YPD + DMSO) or (D) CAS at 0.01 mg/L, 0.025 mg/L and 0.1 mg/L CAS and control conditions, frozen on-orbit,
and cell counts were completed following the mission. * p < 0.05, ** p < 0.006, Flight vs. Terrestrial (A,B); treated vs. sham (C,D).
4. Discussion
As increasing numbers of people spend longer amounts of time in space, it is impera-
tive to understand the physiological adaptations that humans may experience as well as
the threats they may encounter. C. albicans is important in its own right as an opportunistic
pathogen, but as a eukaryotic organism, it may also provide a simple system that affords
insight into how more compl x eukaryotes respond to the environm nt of micr gravity.
That said, a thorough nd robust investig tion of b logical adaptation to microgravity is
comp ic ted for a variety of re ons. Importantly, microgravity ca not be repl cated on
Earth. D vices that have been dev l ped as sim lation bi rea tors hav not been fully
evaluated to determine which aspects of microgravity they simulate, nor the reliability
and predictive value they provide. Secondly, opportunities to conduct experiments in true
microgravity provide challenges in terms of cost, opportunity, procedures, and outcome
measures. Whether utilizing the ISS, suborbital platforms, or free-flyer independent pay-
loads, the conditions, processes, and hardware tend to be unfamiliar and different from
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those used to establish the foundational studies on which the experimental concepts have
been developed. Finally, payload numbers and size tend to be limited, thereby constraining
replicate numbers, ability to repeat experiments, and the breadth of experimental variables
that can be tested. As such, we feel very fortunate to have flown C. albicans on several
missions, allowing for comparison of a subset of outcome measures, across flight opportu-
nities, in different types of hardware, and with reference to results obtained in the HARV
bioreactor as a simulation device.
When planning flight experiments there are mission-dependent events that will frame
the overall timing of experimental procedures and processes, and importantly, the health
and wellness of biological samples. This is a feature rarely encountered in normal ground-
based experiments and must be thoroughly considered when planning flight payloads.
Based on our experience, the time during which samples must be self-sustaining and with-
out active intervention has shortened, but still involves multiple days. This is evidenced in
Table 1 when one considers the time from launch to early sample access. In SpX CRS-1, this
time lapse was 149+ h (6+ days), whereas the shortest lapse was 60 h (2.5 days) during SpX
CRS-17. An additional 30–48 h, at minimum, must be added to allow for pre-launch sample
preparation, handover procedures, and time required for vehicle packing. Cumulatively
and regardless of the experimental design, there is likely to be a multi-day period during
which the samples must be stable without crew intervention. At the other end of the
mission, sample return timelines may also be critical for some studies. One can expect
a multi-day travel period from when the samples leave ISS until they are available for
in-lab processing. Beyond the launch and landing time constraints, there is a fair amount
of flexibility for sample processing during the mission. Overall mission length of the SpX
CRS missions has been fairly consistent and range from 21–36 days, with an average of
28 days. Most experiments are likely to be conducted in a fraction of that time but they
all need to be well choreographed, in terms of crew time and equipment availability, with
the other research and priority activities being performed on the ISS. The combination of
complex timing issues and the use of novel hardware and procedures requires significant
planning and modeling beyond that usually employed for standard experiments.
Although each of our payloads was largely developed independently, we embraced
the opportunity to compare basic cellular characteristics of C. albicans cultivated in micro-
gravity across multiple missions (see Table 3 for a summary). The characteristics chosen
for comparison are primarily those associated with virulence, including growth, cell and
colony morphology, and antifungal resistance. In each of the payloads, yeast grew to a
higher density when cultivated in microgravity. Surprisingly, the calculated generation
time increased as the inoculum level rose, likely due to samples reaching a maximal density
sooner, only to reside in stationary phase through the remainder of the growth period.
Only in the FEP bags was the planktonic, ground-based, and generally accepted doubling
time of 90–120 minutes approximated [51]. These data are limited to end-point analyses
since kinetic studies were not performed; therefore, the contributions of rate of growth
versus length of time in stationary phase cannot be distinguished. A potential secondary
effect of yeast growth is the impact that metabolic activity might have on the surrounding
microenvironment, amplified in microgravity due to low fluid shear and lack of convec-
tion and bulk flow. Further studies are required to determine whether the differences in
growth between flight and terrestrial controls may be explained by a cellular impact on
the surrounding microenvironment, including changes in the concentration of nutrients
and waste products [34,52]. In addition, C. albicans produces significant levels of metabolic
gas, such that the pressure within bioreactor units is substantially increased. The impact of
such increased pressure on cell behavior has yet to be analyzed. That said, an increased cell
density of nearly 10-fold was observed in the FPA hardware of Micro-14/FPA when com-
pared to the Micro-6 FPAs. Whether the gas bubble incorporated into the Micro-14 FPAs
impacted access to oxygen or provided a headspace to buffer the buildup of pressure is
unclear. It is also worth noting that the mid-mission storage times and temperatures varied
among the payloads and may have contributed to viability and ultimately cell density. To
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inform the impacts of these variations, pre-flight, ground-based viability studies had been
previously performed with yeast stored in water. Cells remain sufficiently viable during
long term (~30 days) storage at ambient temperature, although viability was highest when
stored at 12 ◦C and next highest at 4 ◦C (unpublished studies). From these results, it seems
unlikely that the modest changes in storage temperature between flight and terrestrial
samples contributed to the observed difference in cell density. These results also led to
flexibility for the pre-growth storage temperature to simplify flight operations and alleviate
the need for on-orbit temperature maintenance equipment, which is often in high demand.
Table 3. Summary of data obtained across missions and in two types of hardware.
Outcome Measure FPA (Micro-6) FPA (Micro-14) FEP (Micro-14)
Cell Growth F > T * Trend F > T F > T
Cell Density Low Intermediate High
Filamentation Low, no change F vs. T Low, no change F vs. T Very low, no change F vs. T
Colony Morphology No change No change No change
Colony Size No change F > T F > T
AmB Resistance F > T F > T F > T
CAS Resistance NA NA F = T
Biofilm None Trend T > F NA
Freeze Stress Resistance NA T > F T > F
* F = Flight; T = Terrestrial.
Unlike many cells, C. albicans is fairly recalcitrant to temperature variations. As such,
C. albicans also retains reasonable viability when frozen in the absence of a cryopreservation
agent. Surprisingly, the data presented in Figure 6D demonstrates that the resilience
is compromised in cells frozen during spaceflight when compared to similarly treated
terrestrial controls. The difference in survival was observed in samples frozen in FEP
bags (Micro-14/FEP) as well as FPAs (Micro-14/FPA; ~6-fold fewer colonies in flight than
terrestrial controls), demonstrating this is a feature consistent across two types of hardware.
We considered the difference in survival secondary to differences in the rate of freezing.
Cells are likely to freeze more slowly in the low convection environment of space, but a
slower rate is typically considered to be advantageous for cell viability [46]. It was also
noted that cells subjected to spaceflight experience more post-undocking temperature
transitions than the terrestrial controls. Mimicking these temperature transitions in ground-
based studies resulted in a loss of cell viability, but not nearly to the extent of that observed
in the studies described in Figure 6D. Membrane integrity is associated with freeze stress;
therefore, we are considering adaptations to the microgravity environment that might
influence membrane composition.
In addition to cell growth and survival, we analyzed the multicellular characteristics of
C. albicans. A complex colony structure (HIW) had been observed in simulation experiments
using the HARV bioreactor; therefore, viable cells were plated upon conclusion of the
spaceflight missions to determine whether this morphological transition was also triggered
in true microgravity. As demonstrated in Figure 7, HIW colonies were not observed
following 24 h of growth in microgravity. Interestingly, a minimum of 5 days in the HARV
was required to produce the complex colony microarchitecture observed [31], yet those
cells went through a daily subculture procedure which may have delayed adaptation to
the low fluid shear environment. It did not seem unreasonable to consider that a shorter
term exposure to true microgravity may trigger similar adaptation responses as observed
in the extended HARV studies. Longer term spaceflight studies are currently underway
to address whether this colony morphology transition simply requires longer exposure to
the true microgravity environment. Although the analysis of colony morphology required
cells to propagate for several days in post-mission gravity conditions, the HARV-induced
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HIW morphology had been quite stable. Re-adaptation to 1g and subsequent loss of
complex colony morphology does not seem a likely explanation for the observed lack of
complex morphology. Biofilm communities were also undetectable in these studies, again
suggesting the timeline of cultivation (24 h) was not sufficient for the development of
complex macrostructures.
Complex colony morphologies of C. albicans are typically associated with an increase
in filamented cells in the population [50]. Therefore, since complex macro-architectures
were not observed in the studies herein, it is not surprising that cell filamentation was also
found to be minimal. Interestingly, microarray studies published as part of the microgravity
experiment conducted on STS-115 identified the upregulation of several genes associated
with filamentous forms of the yeast, including ALS1, ALS4, YTH1, SPT5 and STI1. Other
genes associated with filamentation were either downregulated or unchanged, namely
ALS2, TEC1 and ALS2 [35]. Of particular interest, the expression of form-associated genes
was consistent with the observed low level of filamentation, specifically the gene coding
for hyphal wall protein (HWP1) was unchanged in flight samples (−1.09) and yeast wall
protein (YWP1) was elevated in flight samples (2.1). Current and ongoing studies will
contribute to a more comprehensive understanding of differential gene expression as
related to C. albicans cultivation in microgravity.
One adaptation that has been fairly consistent among flight opportunities and in the
HARV simulation experiments is an increased resistance of C. albcians to AmB (Figure 8
and [31]). In spaceflight, the level of resistance is greater when cells grow to higher densi-
ties (FEP bags), although minimal dose dependence was observed in these same studies.
It appears as though aqueous solutions of AmB are less stable than CAS, which may
contribute to the difference in dose dependency observed between the Micro-6 (10 days of
4 ◦C storage following medium preparation) and the Micro-14/FEP (17 days of storage fol-
lowing medium preparation) experiments, although this loss of function was not predicted
by pre-flight testing. A preliminary explanation is that AmB lost some efficacy during
storage, resulting in drug levels that kept the growth of terrestrial samples in check, but
had a milder impact on cells already observed to grow to a higher density in microgravity.
The yeast susceptibility to CAS indicates that antifungal resistance is not broad spectrum
and the difference between CAS and AmB may provide clues as to the molecular pathways
that accompany the adaptation processes to microgravity. Specifically, we are evaluating
the role of ergosterol in the adaptation process as it is described as being a cellular target
for AmB cell association and pore formation [53].
Cell and colony morphology can be used as indicators as to the composition of the local
environment since environmental stresses often lead to morphological transformations,
including filamentation and colony extrusions [17]. As observed in Figure 7, cells from
this study produced colonies with a spikey (or foot projection)-style colony morphology
often associated with cells exposed to environmental stresses, such as increased levels of
CO2 [8,54]. These studies suggest that cells cultivated in microgravity may produce and
then respond to a microenvironment enriched in CO2 and other waste products. Since both
flight and terrestrial samples demonstrated the colony projections, it will be important
to parse out the contributions of microgravity relative to the environment created within
specific hardware. Indeed, whether different types of flight hardware modulate or mask the
effects of microgravity is an important consideration in these and other spaceflight studies.
There exists a limited, but useful inventory of spaceflight-compatible hardware within the
industry, with more being developed continuously. Identifying features that are necessary
for successful operations is important and potentially challenging. In the case of C. albicans,
hardware choices were constrained by safety precautions related to potential virulence
and by the metabolic gas production during growth. This gas production precluded the
use of several hardware models because the integrity of individual compartments was
routinely compromised by the internal pressure created by metabolic gas. Thus, hardware
that provided significant replicative capacity was restricted (for example multi-well units
could not withstand the internal pressures produced by the yeast gas production) and
Life 2021, 11, 283 22 of 24
some in-flight analyses were deemed less likely to succeed (microscopy, optical density
measurements) due to the presence of extensive bubble formation. Thus, hardware choices
for microgravity experiments need to be well-vetted and compromises may need to be
made in the name of safety and feasibility. It is in this context that the data herein must be
interpreted. With limited numbers of replicates, and the corresponding distribution of values,
it was encouraging to identify consistent trends in the data. As summarized in Table 3, cells
grew to a higher density in microgravity and produce slightly larger colonies than did
the terrestrial controls. There was also a consistent trend toward increased resistance to
the antifungal agent, AmB. The yeast did not exhibit a filamentation response regardless
of conditions, and the colony architecture was not different between samples cultivated
in microgravity and the terrestrial controls. We noticed that when there were differences
between flight and terrestrial controls, those differences were amplified when the cells
grew to a higher density, especially in the FEP bag hardware.
The complexity associated with spaceflight experiments and the challenges associated
with them dictates the importance of determining whether, and to what extent, ground-
based simulators can be predictive of cellular adaptation to the microgravity environment.
As such, it is important for investigators to continue exploring biological systems in
a variety of spaceflight hardware and to relate those studies to each other as well as
ground-based simulators. Comprehensive analyses of these systems in space and on Earth
will provide a guide for the predictability of ground-based models and a foundation for
investigators to evaluate flight hardware.
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